The following table details the trading activities
(stock purchases, stock sales, and stock option exercises)
the Securities and Exchange Commission (SEC)
by insider Worland Stephen T since year 2005.
The trader's CIK number is 1283307.
At the time of this reporting, Worland Stephen T is the President and CEO of Anadys Pharmaceuticals Inc .
(stock ticker symbol ANDS).
See this page for all insider trading activities at Anadys Pharmaceuticals Inc .
|Trade Date||Symbol||Company Name (Issuer)||Trade Type||Shares||Price ($)||Value ($)|
|2008-05-30||ANDS||Anadys Pharmaceuticals Inc||Option Ex||33,898||2.95||99,999|
|2007-09-04||ANDS||Anadys Pharmaceuticals Inc||Buy||13,236||2.34||31,038|
|2007-08-31||ANDS||Anadys Pharmaceuticals Inc||Buy||12,200||2.12||25,815|
|2007-08-30||ANDS||Anadys Pharmaceuticals Inc||Buy||124,564||2.00||249,128|
|2007-01-12||ANDS||Anadys Pharmaceuticals Inc||Option Ex||25,000||2.95||73,750|
|2006-03-16||ANDS||Anadys Pharmaceuticals Inc||Sale||4,000||16.00||64,000|
|2006-03-02||ANDS||Anadys Pharmaceuticals Inc||Sale||3,000||14.00||42,000|
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Worland Stephen T (President and CEO of Anadys Pharmaceuticals Inc at the time of this reporting) see the Securities and Exchange Commission (SEC) website.